| Overview |
| bs-6309R-PE |
| IL-6 Polyclonal Antibody, PE Conjugated |
| WB, IF(IHC-P) |
| Mouse, Rat |
| Specifications |
| PE |
| Rabbit |
| KLH conjugated synthetic peptide derived from mouse IL-6 |
| Polyclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 16193 |
| Interleukin BSF 2; B cell dferentiation factor; B cell stimulatory factor 2; BSF 2; BSF2; CDF; CTL dferentiation factor; Cytotoxic T cell dferentiation factor; Hepatocyte stimulating factor; HGF; HPGF; HSF; Hybridoma growth factor; Hybridoma plasmacytoma growth factor; NB2; IL 6; IL6 protein; Interferon beta 2; Interleukin 6 interferon beta 2; Interleukin-6; Interleukin6; IL6_HUMAN. |
| IL6 is reported to be produced by fibroblasts, activated T cells, activated monocytes or macrophages and endothelial cells. It acts upon a variety of cells including fibroblasts, myeloid progenitor cells, T cells, B cells and hepatocytes. In addition, IL6 appears to interact with IL2 in the proliferation of T lymphocytes. IL6 potentiates the proliferative effect of IL3 on multipotential hematopoietic progenitors. |
| Application Dilution |
| WB |
|
| IF(IHC-P) |
|
Powered by Bioz